Oligomerization of opioid receptors: generation of novel signaling units.
about
Receptor heteromerization and drug discovery.Opioid ligands with mixed mu/delta opioid receptor interactions: an emerging approach to novel analgesicsLipid- and sugar-modified endomorphins: novel targets for the treatment of neuropathic painSelective interactions between helix VIII of the human mu-opioid receptors and the C terminus of periplakin disrupt G protein activationA bivalent ligand (KMN-21) antagonist for mu/kappa heterodimeric opioid receptorsA Role for the Distal Carboxyl Tails in Generating the Novel Pharmacology and G Protein Activation Profile of and Opioid Receptor Hetero-oligomersEthanol/naltrexone interactions at the mu-opioid receptor. CLSM/FCS study in live cells.Opioids in the hypothalamus control dopamine and acetylcholine levels in the nucleus accumbens.Opioid-receptor-heteromer-specific trafficking and pharmacology.Effect of μ-opioid agonist DAMGO on surface CXCR4 and HIV-1 replication in TF-1 human bone marrow progenitor cells.Morphine- and CaMKII-dependent enhancement of GIRK channel signaling in hippocampal neuronsDirect and indirect inhibition by nociceptin/orphanin FQ on noradrenaline release from rodent cerebral cortex in vitroPharmacological consequence of the A118G μ opioid receptor polymorphism on morphine- and fentanyl-mediated modulation of Ca²⁺ channels in humanized mouse sensory neurons.Molecular Pharmacology of δ-Opioid Receptors.Dopamine receptor homooligomers and heterooligomers in schizophreniaOpioid receptors: from binding sites to visible molecules in vivo.G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function.Purification and functional reconstitution of monomeric mu-opioid receptors: allosteric modulation of agonist binding by Gi2.Antinociceptive effects of two deltorphins analogs in the tail-immersion test in rats.Pharmacological Profiles of Oligomerized μ-Opioid Receptors.G-protein-coupled heteromers: regulation in diseasePlatforms for the identification of GPCR targets, and of orthosteric and allosteric modulators.The R7 subfamily of RGS proteins assists tachyphylaxis and acute tolerance at mu-opioid receptors.Neurotransmitter receptor complexes: methods for bioanalysis, their potentials and limitations.The design of multitarget ligands for chronic and neuropathic pain.Agonists at the δ-opioid receptor modify the binding of µ-receptor agonists to the µ-δ receptor hetero-oligomer.Co-expression of mu and delta opioid receptors as receptor-G protein fusions enhances both mu and delta signalling via distinct mechanisms.Opioids in the hypothalamic paraventricular nucleus stimulate ethanol intake.Interaction between alpha(1)- and alpha(2)-adrenoreceptors contributes to enhanced constrictor effects of norepinephrine in mesenteric veins compared to arteriesSynthesis and binding affinity of novel mono- and bivalent morphinan ligands for κ, μ, and δ opioid receptors.Activation of delta- and kappa-opioid receptors by opioid peptides protects cardiomyocytes via KATP channels.Morphine withdrawal precipitated by specific mu, delta or kappa opioid receptor antagonists: a c-Fos protein study in the rat central nervous system.The delta agonists DPDPE and deltorphin II recruit predominantly mu receptors to produce thermal analgesia: a parallel study of mu, delta and combinatorial opioid receptor knockout mice.Cross-sensitization between the locomotor stimulant effects of ethanol and those of morphine and cocaine in mice.Purification and mass spectroscopic analysis of human CB2 cannabinoid receptor expressed in the baculovirus system.Dopamine receptor oligomerization visualized in living cells.
P2860
Q24631740-1343BBAB-D8C2-4E34-B067-A066E158075EQ24647687-0F6C021F-9B17-4A34-8799-D5445728153BQ26991917-5CA6FFA8-7093-45C3-989D-5317670D4B88Q28179746-86539627-3B9B-44D7-AC6A-0394F3ED91E7Q28822182-1E6CB54E-CD02-423C-B7F9-2928B9B563C7Q30053100-80E1B7B8-9F41-4EC7-A732-CAF960391A17Q33395349-33743A01-91CC-43A3-81A3-E0AA830407E0Q33666303-33DB97D2-F243-403C-B74A-6525107307E2Q33978499-16EC3758-11A7-40EA-B91F-56B6FE30A087Q34436453-017048D1-AEB1-4866-875F-320D7A49D3DEQ34440710-9B4EB5F2-C51D-475C-AF50-E67D456CABFFQ35044530-501572F7-A87E-4CA6-A0A3-F84D059C13D0Q35464108-394BB86C-F9B0-4E85-88A1-A646E6D65C50Q37062556-712225CF-EBA1-4072-B93A-FFCE8A68B29EQ37242424-3F7EC251-4F9A-4245-8C2A-2CE4C8295EB2Q37249017-4EA53F3B-3557-4E6D-B032-58C7BCFBC1FDQ37421818-05995DC9-5877-4055-9C6E-DE05C88BFB2BQ37446783-5399305D-0B0C-4C92-9C36-F87BC8C22B37Q37603306-8CBFE8D5-1DF4-4598-B0DC-0ACD0036A880Q37679197-6CD766E0-9BF0-42CE-A8A5-EC46241B9A37Q37686142-A4A1D410-BFB1-4D11-A9E4-6FA065902E06Q38028542-2D7AB3E6-E2E7-41FE-9353-95279526CC6AQ38351795-22D40467-6D6D-4919-A6CC-015BE410BC00Q38613063-C09DC26C-9133-47F0-B9D2-E0A9D8895A48Q38664916-4288C2DE-D717-4DBE-9210-D8506E69D4CBQ39639691-8E8FD681-8195-4169-B95D-A7E15CEAC481Q40027304-66E9AD0C-7E0D-444E-A2CA-277326AEFF04Q42108841-4A9B3029-8662-4200-8843-7373E3BC8CB7Q42526980-3D900E46-DA93-4883-A0EF-FFE23CA986F9Q42734840-D659D684-60B8-435D-8E7E-5B8F8D7F6537Q44341449-FCC63005-0310-4307-AD8F-27E026A09BE9Q44341922-B4AD9884-84EE-4600-934D-C14464E18755Q44345198-F22A4AA6-032E-42E9-B42C-6BC9551D8E5DQ44414841-5DBF6CC7-FFA3-43AD-83C4-6B8D8EB082D5Q45216079-C9262CFB-E486-434C-80A8-09EDCEA65D41Q46663693-EF97ECEB-2966-496E-AAB6-85FE492D3887
P2860
Oligomerization of opioid receptors: generation of novel signaling units.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Oligomerization of opioid receptors: generation of novel signaling units.
@ast
Oligomerization of opioid receptors: generation of novel signaling units.
@en
Oligomerization of opioid receptors: generation of novel signaling units.
@nl
type
label
Oligomerization of opioid receptors: generation of novel signaling units.
@ast
Oligomerization of opioid receptors: generation of novel signaling units.
@en
Oligomerization of opioid receptors: generation of novel signaling units.
@nl
prefLabel
Oligomerization of opioid receptors: generation of novel signaling units.
@ast
Oligomerization of opioid receptors: generation of novel signaling units.
@en
Oligomerization of opioid receptors: generation of novel signaling units.
@nl
P2093
P1476
Oligomerization of opioid receptors: generation of novel signaling units.
@en
P2093
Brandon A R Levac
Brian F O'Dowd
Susan R George
P356
10.1016/S1471-4892(02)00124-8
P577
2002-02-01T00:00:00Z